Log In
Print
BCIQ
Print
Print this Print this
 

Doravirine (MK-1439)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNon-nucleoside HIV reverse transcriptase inhibitor (NNRTI)
Molecular Target HIV reverse transcriptase
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection in treatment-naïve patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today